Published in Cancer Weekly, January 7th, 2003
F. Tanaka and colleagues, University of Tokyo, reported, "Substantial antitumor effects were observed when established MCA205 fibrosarcoma was treated in syngeneic immunocompetent mice with intratumoral injection of Ad.PTH.IL-18 (p=0.0025 versus control vector treatment), generating potent cytotoxic T lymphocytes (CTLs) in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.